Chlorzoxazone can effectively reduce the expression of STAT3, NFκB1, and EZH2, and upregulate FOXL1, therefore, it might be an effective drug for DLBCL. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.